Effects of the new, non benzodiazepine, anxiolytic drug buspirone on the serotonergic system

F. Fodritto, L. Imeri, A. De Luigi, M. G. De Simoni

Research output: Contribution to journalArticle

Abstract

The effects of the new, non benzodiazepine, anxiolytic drug buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine (1-PP) were studied on the serotonergic system by in vivo voltammetry. This technique, in association with carbon fiber microelectrodes, chronically implanted in the hippocampus, caudate nucleus and nucleus accumbens of freely moving rats, continuously recorded 5-hydroxy-indoleacetic acid (5HIAA), the serotonin metabolite, in the extracellular space. The administration of buspirone (10 mg/kg i.p.) induced a decrease in 5HIAA in the hippocampus but not in the caudate nucleus and nucleus accumbens. This effect lasted about 150 min; 1-PP was found to be ineffective. The regional specificity of buspirone suggests a role for hippocampal serotonin in anxiety.

Original languageEnglish
Pages (from-to)200-202
Number of pages3
JournalMedicina - Rivista della Enciclopedia Medica Italiana
Volume8
Issue number2
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Effects of the new, non benzodiazepine, anxiolytic drug buspirone on the serotonergic system'. Together they form a unique fingerprint.

  • Cite this